WORKING TOWARDS BETTER RHEUMATIC AND ARTHRITIS RESEARCH - TOGETHER
News Rheum is a quarterly newsletter created in response to feedback from patient insight partners at our first Patient Voice in Arthritis Research discussion forum. It is co-produced by patients and researchers with each edition focussing on a specific theme.
Subscribe to the newsletter here
To access the newsletters, click the links below.
F. Yap et al., HLA-DRB1 and HLA-DQA1 associated with immunogenicity to adalimumab therapy in patients with rheumatoid arthritis. Ann Rheum Dis 83, 263-265 (2024).
Sepriano et al., Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort. Clin Rheumatol 43, 1833-1844 (2024).
Schwerdt, G. Christe, J. W. Pate, C. Blake, K. M. Smart, The prevalence of chronic pain in adolescents in Central Switzerland: A cross- sectional school-based study protocol. PLoS One 19, e0297088 (2024).
Pryce et al., Patients' experiences following total knee arthroplasty: a qualitative evidence synthesis. Disabil Rehabil 46, 214-231 (2024).
Pascart et al., Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyrophosphate Deposition Classification Criteria Cohort. Arthritis Rheumatol 10.1002/art.42962 (2024).
M. McCarthy, J. Stack, Osteoarthritis and basic calcium phosphate crystals - The enemy lurks within! Osteoarthritis Cartilage 10.1016/j.joca.2024.07.015 (2024).
B. Casey, K. M. Smart, A survey of physiotherapist managers in Ireland and their views on the role of Advanced Practice Physiotherapists. Physiother Res Int 29, e2064 (2024).
F. Ling et al., A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures. Rheumatology (Oxford) 63, 1015-1021 (2024).
F. Ling et al., Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis. Pharmaceutics 16 (2024).
S. Hinwood et al., The experiences of people living with obesity and chronic pain: A Qualitative Evidence Synthesis (QES) protocol. PLoS One 19, e0302051 (2024).
FitzGerald et al., Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical Responses. Arthritis Rheumatol 76, 1397-1407 (2024).
Charles-Schoeman et al., Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years. Rheumatol Ther 11, 157-175 (2024).
A. Sumpter et al., Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout. Arthritis Rheumatol 75, 816-825 (2023).
L. Smith et al., Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis. Ann Rheum Dis 82, 611-620 (2023).
M. Smart, Pain science and practice as a 'threshold concept' within undergraduate and pre-registration physiotherapy education: a jewel of the curriculum? BMC Med Educ 23, 732 (2023).
O'Leary et al., HLA-B*27 is associated with CNO in a European cohort. Pediatr Rheumatol Online J 21, 52 (2023).
Nair, A. G. Wilson, Assessing the potential of epigenetic targets as biomarkers in the diagnosis and treatment of rheumatoid arthritis. Expert Rev Clin Immunol 19, 483-488 (2023).
Y. Leung et al., Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. J Rheumatol 50, 119-130 (2023).
Kluck et al., A functional genomics approach reveals suggestive quantitative trait loci associated with combined TLR4 and BCP crystal-induced inflammation and osteoarthritis. Osteoarthritis Cartilage 31, 1022-1034 (2023).
M. Hum et al., Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis. Rheumatology (Oxford) 62, 2090-2097 (2023).
Chhana et al., Basic calcium phosphate crystals induce the expression of extracellular matrix remodelling enzymes in tenocytes. Rheumatology (Oxford) 62, 1343-1349 (2023).